share_log

Reneo Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-I.R.S. IDENTIFICATION NO. John P. McKearn, Ph.D.(7.53%),I.R.S. IDENTIFICATION NO. Jay Schmelter(7.53%), etc.

Reneo Pharmaceuticals | SC 13D/A:超過5%持股股東披露文件(修正)-I.R.S. IDENTIFICATION NO. John P. McKearn, Ph.D.(7.53%),I.R.S. IDENTIFICATION NO. Jay Schmelter(7.53%)等

SEC announcement ·  2023/05/30 16:52
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息